Sort
85,873 grants matching “alzheimers”
Wyoming Sensory Biology COBRE
$2,480,469Qianquan Sun · University Of Wyoming · P20 · FY2024 · GM
ALZHEIMERS DISEASE RESEARCH CENTER
$2,479,791University Of California San Diego · P50 · FY2000 · AG
From cells to complex syndromes: using networks to understand heterogeneity in TDP-related frontotemporal degeneration and aging
$2,479,787Corey T McMillan · University Of Pennsylvania · P01 · FY2022 · AG
Roles Of Brain Neuroimmune System In Neurodegeneration
$2,479,625Jau-Shyong Shyong Hong · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
From cells to complex syndromes: using networks to understand heterogeneity in TDP-related frontotemporal degeneration and aging
$2,479,382Corey T McMillan · University Of Pennsylvania · P01 · FY2023 · AG
EPIDEMIOLOGY OF DEMENTIA IN AN URBAN COMMUNITY
$2,479,208Columbia University Health Sciences · P01 · FY2001 · AG
Nurse Led Telephonic Care
$2,479,057Abraham Aizer Brody · New York University School Of Medicine · U19 · FY2023 · AG
From cells to complex syndromes: using networks to understand heterogeneity in TDP-related frontotemporal degeneration and aging
$2,479,031Corey T McMillan · University Of Pennsylvania · P01 · FY2024 · AG
Federated Deep Learning to Accelerate Alzheimer's Disease Research
$2,477,877Paul M Thompson · University Of Southern California · RF1 · FY2025 · AG
Alzheimer's Disease Research Center
$2,477,081Murray A Raskind · University Of Washington · P50 · FY2006 · AG
PREVENTABLE Data Coordinating Center
$2,476,924Bradley G Hammill · Duke University · U19 · FY2019 · AG
Routes to enhanced HIV neuropathogenesis through expression of subclinical levels of endogenous amyloid-beta
$2,475,013David J Volsky · Icahn School Of Medicine At Mount Sinai · RF1 · FY2022 · NS
ALZHEIMERS DISEASE RESEARCH CENTER
$2,474,366John Morris · Washington University · P50 · FY2012 · AG
The POINTER Neurovascular Ancillary Study
$2,474,352Tina E Brinkley · Wake Forest University Health Sciences · R01 · FY2020 · AG
Elucidating factors that modulate tauopathy and cellular degeneration to guide therapeutic development
$2,473,595Jada M Lewis · University Of Florida · RF1 · FY2019 · AG
Early Onset AD Consortium - the LEAD Study (LEADS)
$2,473,288Liana G Apostolova · Indiana University Indianapolis · U01 · FY2019 · AG
Longitudinal validation of cerebral small vessel disease biomarkers in diverse community-based older adults without dementia
$2,472,997Konstantinos Arfanakis · Rush University Medical Center · UF1 · FY2021 · NS
Leveraging Big Data to Improve Women's Health (BD-WH)
$2,471,413Heather R Desaire · University Of Kansas Lawrence · P20 · FY2025 · GM
Establishing the science behind Alzheimer's recruitment registries: opportunities for increasing diversity and accelerating enrollment into trials
$2,470,609Jessica Brooke Langbaum · Banner Health · R01 · FY2022 · AG
Aging, Cognition, and Hearing Evaluation in Elders (ACHIEVE) Randomized Trial
$2,469,860Frank R Lin · Johns Hopkins University · R01 · FY2019 · AG
Alzheimer's Disease Research Center
$2,468,786Murray A Raskind · University Of Washington · P50 · FY2007 · AG
From cells to complex syndromes: using networks to understand heterogeneity in TDP-related frontotemporal degeneration and aging
$2,467,715Murray Grossman · University Of Pennsylvania · P01 · FY2021 · AG
Dissecting the role of the dentate gyrus microcircuit to improve cognitive discrimination in aging and Alzheimer's Disease
$2,467,494Attila Losonczy · Columbia University Health Sciences · RF1 · FY2023 · AG
Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors
$2,466,073Robert A Stern · Boston University Medical Campus · U01 · FY2017 · NS
Septhohippocamal connectome dysfunction in Down syndrome associated with Alzheimerâs disease pathophysiology
$2,466,001Stephen D. Ginsberg · New York University School Of Medicine · RF1 · FY2023 · AG